These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 21738242)

  • 1. Diagnostic criteria of antibody-mediated rejection in kidney transplants.
    Mosquera Reboredo JM; Vázquez Martul E
    Nefrologia; 2011; 31(4):382-91. PubMed ID: 21738242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.
    Sis B; Halloran PF
    Curr Opin Organ Transplant; 2010 Feb; 15(1):42-8. PubMed ID: 20009933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of chronic humoral rejection.
    Colvin RB
    Contrib Nephrol; 2009; 162():75-86. PubMed ID: 19001815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of antibody-mediated kidney allograft rejection.
    Böhmig G; Regele H
    Transpl Int; 2003 Nov; 16(11):773-87. PubMed ID: 14534774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
    Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of C4d deposition in antibody-mediated rejection.
    Takeda A; Otsuka Y; Horike K; Inaguma D; Hiramitsu T; Yamamoto T; Nanmoku K; Goto N; Watarai Y; Uchida K; Morozumi K; Kobayashi T
    Clin Transplant; 2012 Jul; 26 Suppl 24():43-8. PubMed ID: 22747475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [C4d: a pathogenetically relevant marker in kidney transplantation].
    Regele H
    Verh Dtsch Ges Pathol; 2004; 88():89-97. PubMed ID: 16892538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic analysis of acute vascular rejection cases after renal transplantation.
    Shimizu T; Tanabe T; Omoto K; Ishida H; Tanabe K
    Transplant Proc; 2012 Jan; 44(1):230-5. PubMed ID: 22310621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies.
    Yousem SA; Zeevi A
    Am J Surg Pathol; 2012 Jul; 36(7):987-92. PubMed ID: 22510758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of C4d in renal allograft biopsies in different clinical settings: absence of C4d in grafts from non-heart-beating donors.
    Crespo M; Sole M; Arostegui JL; Mila J; Martorell J; Oppenheimer F
    Transplant Proc; 2005 Nov; 37(9):3688-9. PubMed ID: 16386506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypes of antibody-mediated rejection in organ transplants.
    Mengel M; Husain S; Hidalgo L; Sis B
    Transpl Int; 2012 Jun; 25(6):611-22. PubMed ID: 22533649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
    Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New faces of acute rejection in 2008].
    Legendre C
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S297-300. PubMed ID: 19596353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current aspects of acute humoral rejection].
    Legendre C; Loupy A; Rabant M; Aubert O; Rabaté C; Delville M; Tinel C; Amrouche L; Martinez F; Snanoudj R; Bererhi L; Scemla A; Sberro-Soussan R; Duong JP; Suberbielle C; Anglicheau D
    Nephrol Ther; 2014 Nov; 10(6):479-83. PubMed ID: 25440942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological analysis of late renal allografts of antidonor antibody positive patients with C4d deposits in peritubular capillaries.
    Aita K; Yamaguchi Y; Shimizu T; Horita S; Furusawa M; Tanabe K; Fuchinoue S; Toma H
    Clin Transplant; 2004; 18 Suppl 11():7-12. PubMed ID: 15191366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis.
    Colvin RB
    J Am Soc Nephrol; 2007 Apr; 18(4):1046-56. PubMed ID: 17360947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts.
    Torrealba JR; Samaniego M; Pascual J; Becker Y; Pirsch J; Sollinger H; Odorico J
    Transplantation; 2008 Dec; 86(12):1849-56. PubMed ID: 19104433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Banff 2013 update: Pearls and pitfalls in transplant renal pathology.
    Hara S
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():2-8. PubMed ID: 26031578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of acute humoral rejection using immunofluorescence in renal allograft biopsies- one step towards better understanding!
    Vanikar AV; Trivedi H; Patel RD; Kanodia KV; Trivedi VB; Shah PR; Gupta SB; Dabhi M; Gumber M; Goplani K
    Indian J Pathol Microbiol; 2007 Jul; 50(3):502-6. PubMed ID: 17883118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.